The tumor exhibited a peak [68Ga]PSMA-11 concentration of 4.5 ± 0.7 %ID/g 2 h (on average) after the injection, which decreased gradually thereafter, measuring approximately 3 %ID/g after 5 h. The gene discussed is FOLH1; the disease is neoplasm.